Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Other Operating Expenses (2024 - 2025)

Beta Bionics' Other Operating Expenses history spans 2 years, with the latest figure at $16.3 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 51.18% year-over-year to $16.3 million; the TTM value through Dec 2025 reached $61.4 million, up 65.57%, while the annual FY2025 figure was $61.4 million, 65.57% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $16.3 million at Beta Bionics, up from $16.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $16.3 million in Q4 2025 and bottomed at $7.7 million in Q1 2024.